Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fasanmade

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
International Wound Journal|November 17, 2009
Diabetes foot ulceration in a Nigerian hospital: in-hospital mortality in relation to the presenting demographic, clinical and laboratory featuresChukwuma O Ekpebegh, Sandra O Iwuala, Olufemi A Fasanmade, et al.
Journal of AOAC International|September 13, 2005
Kinetics of thermal decomposition of 4-carboxyl-2,6-dinitrobenzenediazonium ion (CDNBD)Olakunle S Idowu, Abiola O Kolawole, Olajire A Adegoke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findingsM E Dolan, S K Roy, A A Fasanmade, et al.
European Journal of Clinical Pharmacology|September 17, 2009
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitisAdedigbo A Fasanmade, Omoniyi J Adedokun, Joyce Ford, et al.
Arthritis and Rheumatism|July 13, 2002
The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trialE William St Clair, Carrie L Wagner, Adedigbo A Fasanmade, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Prevalence of dysglycemia in Calabar: a cross-sectional observational study among residents of Calabar, NigeriaO E Enang, A A Otu, O E Essien, et al.
Ethnicity & Disease|August 7, 2013
Rural-urban difference in plasma lipid levels and prevalence of dyslipidemia in Hausa-Fulani of north-western NigeriaA A Sabir, S A Isezuo, A E Ohwovoriole, et al.
Journal of the American Academy of Dermatology|January 11, 2003
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgarisAlice B Gottlieb, Salman Masud, Rallapalli Ramamurthi, et al.
Nigerian Medical Journal : Journal of the Nigeria Medical Association|November 20, 2013
Endocrine-related diseases in the emergency unit of a Tertiary Health Care Center in Lagos: A study of the admission and mortality patternsA C Anyanwu, I A Odeniyi, O A Fasanmade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2016
Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal MalignanciesKhaldoun Almhanna, Thea Kalebic, Cristina Cruz, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
International Wound Journal|November 17, 2009
Diabetes foot ulceration in a Nigerian hospital: in-hospital mortality in relation to the presenting demographic, clinical and laboratory featuresChukwuma O Ekpebegh, Sandra O Iwuala, Olufemi A Fasanmade, et al.
Journal of AOAC International|September 13, 2005
Kinetics of thermal decomposition of 4-carboxyl-2,6-dinitrobenzenediazonium ion (CDNBD)Olakunle S Idowu, Abiola O Kolawole, Olajire A Adegoke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findingsM E Dolan, S K Roy, A A Fasanmade, et al.
European Journal of Clinical Pharmacology|September 17, 2009
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitisAdedigbo A Fasanmade, Omoniyi J Adedokun, Joyce Ford, et al.
Arthritis and Rheumatism|July 13, 2002
The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trialE William St Clair, Carrie L Wagner, Adedigbo A Fasanmade, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Prevalence of dysglycemia in Calabar: a cross-sectional observational study among residents of Calabar, NigeriaO E Enang, A A Otu, O E Essien, et al.
Ethnicity & Disease|August 7, 2013
Rural-urban difference in plasma lipid levels and prevalence of dyslipidemia in Hausa-Fulani of north-western NigeriaA A Sabir, S A Isezuo, A E Ohwovoriole, et al.
Journal of the American Academy of Dermatology|January 11, 2003
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgarisAlice B Gottlieb, Salman Masud, Rallapalli Ramamurthi, et al.
Nigerian Medical Journal : Journal of the Nigeria Medical Association|November 20, 2013
Endocrine-related diseases in the emergency unit of a Tertiary Health Care Center in Lagos: A study of the admission and mortality patternsA C Anyanwu, I A Odeniyi, O A Fasanmade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2016
Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal MalignanciesKhaldoun Almhanna, Thea Kalebic, Cristina Cruz, et al.
Pageof 10